about
Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicityNatural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formationIn vitro inhibition of transthyretin aggregate-induced cytotoxicity by full and peptide derived forms of the soluble receptor for advanced glycation end products (RAGE)Human metallothioneins 2 and 3 differentially affect amyloid-beta binding by transthyretinSynergy of combined doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse modelsTransthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolutionStructural basis for the protective role of sulfite against transthyretin amyloid formationIodination of salicylic acid improves its binding to transthyretinIodine Atoms: A New Molecular Feature for the Design of Potent Transthyretin Fibrillogenesis InhibitorsStructural insights into a zinc-dependent pathway leading to Leu55Pro transthyretin amyloid fibrilsA primer of amyloid nomenclatureEpigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice modelsMolecular Tweezers Targeting Transthyretin AmyloidosisNew transthyretin mutation V28M in a Portuguese kindred with amyloid polyneuropathy.A novel compound heterozygote (FAP ATTR Arg104His/ATTR Val30Met) with high serum transthyretin (TTR) and retinol binding protein (RBP) levels.Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors.Transthyretin and Alzheimer's disease: where in the brain?Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor.Differential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune system.Transthyretin amyloidosis: a tale of weak interactions.Transthyretin mutations in health and disease.Interleukin-1 signaling pathway as a therapeutic target in transthyretin amyloidosis.Distinct annular oligomers captured along the assembly and disassembly pathways of transthyretin amyloid protofibrilsStability of the transthyretin molecule as a key factor in the interaction with a-beta peptide--relevance in Alzheimer's disease.Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis.Glial cells in familial amyloidotic polyneuropathyHeparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein.Transthyretin Induces Insulin-like Growth Factor I Nuclear Translocation Regulating Its Levels in the HippocampusNeurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling.Biomarkers in the assessment of therapies for familial amyloidotic polyneuropathy.C1q ablation exacerbates amyloid deposition: A study in a transgenic mouse model of ATTRV30M amyloid neuropathy.Transthyretin participates in beta-amyloid transport from the brain to the liver--involvement of the low-density lipoprotein receptor-related protein 1?Transthyretin Ser 6 gene frequency in individuals without amyloidosis.Curcumin: A multi-target disease-modifying agent for late-stage transthyretin amyloidosis.Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis.Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targetingTransthyretin provides trophic support via megalin by promoting neurite outgrowth and neuroprotection in cerebral ischemiaClearance of extracellular misfolded proteins in systemic amyloidosis: experience with transthyretin.Transthyretin: a multifaceted protein.Production of recombinant human transthyretin with biological activities toward the understanding of the molecular basis of familial amyloidotic polyneuropathy (FAP).
P50
Q24311309-59BCE2DD-1F43-4126-B83F-E785EF854F38Q24311960-E9ED6578-101C-41D1-8790-93897FC36C05Q24337632-BBED3D33-7CBF-4221-93E8-CF628AEEDBA8Q24339434-61CAB9B3-200D-496F-A8DB-71D3C22F87DAQ24631610-DC973084-BBBF-4A7E-8EBB-DB85A8C65E2BQ27630461-7B7CC04E-DD3E-4818-BF04-F45F0BCF9235Q27643343-04392BC6-6AA9-4331-AC10-E7BF7B30DA4BQ27649397-EF7CF7CC-E768-4666-AE45-613ECDD71D6FQ27653350-A2DE535A-3F24-48AE-BA5C-A921365A804DQ27675841-479EB5C0-0977-4275-A357-36BE283BA5E5Q28241008-F7063C08-F688-4F22-8853-B14EA6CDA47FQ28478763-B40FAA61-90FC-4649-A441-1CDCC5E398BDQ29030065-B43B9603-A241-4D69-AB0E-4B3DA755E7EFQ30651190-FDD7EAA8-F55B-4257-B7F0-37489A8208B3Q30797179-970A9E82-17C2-4AEE-B1D0-3AFAF33667C7Q31153089-11BE0EBD-D810-497D-86F2-F69E5C320C98Q33243335-523D7DC9-2934-4A64-8B04-C16ABB3A4CA7Q33358106-363FB7A1-E13D-4597-A62C-68BC654B1D7BQ33768132-409195EA-783A-4572-80F8-A66652F774C6Q34286109-FEE40391-4CF1-499F-BDE8-850F42EE3C40Q34298981-DABF78EC-6455-4E91-82F9-DAB30304DE24Q34336131-1C4FD6E0-2113-4969-944A-D1CCC0E254F9Q34416296-E5FA419F-B4D7-4037-A351-53B5149C4813Q34428889-35C4DB45-B591-4E33-9B6A-4AB6EA0B5FD5Q34559858-3C7CEA4C-3E4E-43FB-9B56-8DA4EB41BC04Q34793765-814BAABB-5B0F-46D2-A6D5-74BF4A4B3D7CQ34805156-FB553BF7-FFBB-4A13-B7A8-5EF727BB6EB2Q35616785-8577C7EC-90D8-43DD-9114-E9C4B88513E6Q35646136-1606388E-281A-4518-951D-2E408E241DBBQ36057473-37947104-D308-4AA6-B64F-B254B750D039Q36346078-0DF76EDC-052C-4C76-98DB-EBEEC2C1728FQ36536181-028947E3-AAB8-4B59-8A49-20C551B7533BQ36717157-4CD96642-E16A-4E7F-86F6-8185E3FFCA57Q36919063-115CFBF3-72B1-44CB-AC45-FA78092C69B6Q36981555-A34EE9B5-1914-4900-8550-51FE5A78046DQ37126036-DA4909C2-0913-454C-ABF4-5CE8578D837AQ37352120-D5D8C2C5-C17C-469C-80C7-F5B94BBCD808Q38028212-83505E37-C9DA-4A91-BE2A-517228E43B2FQ38265279-92F8FAB8-B2AD-4259-A915-16D5B4C7EC68Q38336219-59EFFD15-E5E1-46B0-8F43-F018FB2C0660
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Maria João Saraiva
@ast
Maria João Saraiva
@en
Maria João Saraiva
@es
Maria João Saraiva
@nl
Maria João Saraiva
@sl
type
label
Maria João Saraiva
@ast
Maria João Saraiva
@en
Maria João Saraiva
@es
Maria João Saraiva
@nl
Maria João Saraiva
@sl
altLabel
Maria Joao Saraiva
@en
prefLabel
Maria João Saraiva
@ast
Maria João Saraiva
@en
Maria João Saraiva
@es
Maria João Saraiva
@nl
Maria João Saraiva
@sl
P214
P1053
K-3907-2013
P106
P1153
16944355500
6603096999
P21
P213
0000 0000 6910 3711
P214
P31
P3829
P496
0000-0002-3360-6899
P734
P735
P7859
viaf-99377037